StockpollyBeta
Get App
Delisting riskPopularity #4,533
DSS · AMEX · Packaging & Containers

DSS (DSS)

Operates custom packaging and security printing with lending, biotechnology, and investment businesses.

$0.7126
After-hours close−0.00 (−0.01%)
At close$0.7127(−3.49%)

  1. DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical's Proposed Business Combination with Zoar Limited

    GlobeNewsWire

  2. DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations

    GlobeNewsWireProduct

  3. DSS Shares Crash After Soaring. What the New Offering Means for Investors

    GuruFocusFinancing

  4. DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering

    GlobeNewsWireFinancing

  5. DSS, Inc. Announces Launch of Proposed Public Offering

    GlobeNewsWireFinancing

  6. DSS, Inc. Withdraws Registration Statement

    GlobeNewsWire

  7. DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

    GlobeNewsWire

  8. DSS, Inc. Letter to Shareholders

    Globe News Wire

  9. DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering

    GlobeNewsWire

  10. DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering

    GlobeNewsWire

  11. DSS, Inc. Announces Launch of Proposed Public Offering

    GlobeNewsWire

  12. DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

    GlobeNewsWire

  13. DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

    GlobeNewsWire

  14. DSS, Inc. Issues Letter to Shareholders

    GlobeNewsWire

  15. DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

    GlobeNewsWire

  16. AmericaFirst Funds Trust Announces Changes to Board of Trustees

    GlobeNewsWire

  17. DSS, Inc. Names Jason Grady as Interim Chief Executive Officer

    GlobeNewsWire

  18. Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

    GlobeNewsWire

  19. DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

    GlobeNewsWire

  20. DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

    GlobeNewsWire